Safe HRT Prescribing for the Perimenopause and Menopause - Webinar

Aims
The NICE menopause guidelines were produced in 2015 and clearly state that for the
majority of women, the benefits of taking HRT outweigh any risks. It is currently only the minority of women are taking HRT for their perimenopause and menopause. In addition to improving menopausal symptoms, HRT provides numerous health benefits including a lower future risk of cardiovascular disease, type II diabetes, osteoporosis, depression and dementia. This session will provide you with confidence and knowledge to prescribe HRT to women.

Learning outcomes
Following this session dedicates will be able to:

• Make a diagnosis of the perimenopause and menopause
• Identify those women who will benefit from taking HRT
• Confidently decide which dose and type of HRT to give their patients

Clinical outcomes
It is anticipated that following the session delegates will achieve:

• An improved understanding of the perimenopause and menopause including thelong-term health risks associated with it
• Knowledge of the current evidence to support the effectiveness of prescribing HRT
• The ability to provide individualised consultations for menopausal and perimenopausal women